Clinical Trial Update: AS900672-Enriched in Ovulation Induction [Phase 2]

View source ↗

Summary

Phase 2 trial of AS900672 in ovulation induction was terminated; Merck KGaA posted results in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• AS900672 (AS900672)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Ovulation Induction | Phase 2 | Status: TERMINATED | Results posted: 2013-07-25